Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/06/53/43/06534319-ae24-1c39-a647-a136fa872196/mza_14564616423356070646.jpg/600x600bb.jpg
Criss Cross Tamizh
Criss Cross Tamizh
35 episodes
3 days ago
We are a You Tube channel and if you fell that the videos are too long out there you can now hear only the audio out here.. Sinthipom Seiyal Paduvom Jai Hind..
Show more...
News
RSS
All content for Criss Cross Tamizh is the property of Criss Cross Tamizh and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We are a You Tube channel and if you fell that the videos are too long out there you can now hear only the audio out here.. Sinthipom Seiyal Paduvom Jai Hind..
Show more...
News
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/6506532/6506532-1592890876971-ae8ff196c672d.jpg
Vaccine drive | CoVaxin drive | Details about the covaxin distribution in India
Criss Cross Tamizh
4 minutes 26 seconds
4 years ago
Vaccine drive | CoVaxin drive | Details about the covaxin distribution in India

In this video let us see who will get the first vaccine for covid 19 in india coronavirus covid vaccine covid-19 coronavirus vaccine vaccine covid vaccine india vaccine india coronavirus vaccine india coronavirus india tamil,covid vaccine india tamil India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.  The vaccine received DCGI approval for Phase I & II Human Clinical Trials and the trials commenced across India from July, 2020.  After successful completion of the interim analysis from the Phase 1 & 2 clinical trials of COVAXINTM, Bharat Biotech received DCGI approval for Phase 3 clinical trials in 26,000 participants in over 25 centres across India.  சிந்திப்போம் செயல்படுவோம் வாழ்க தமிழ் வளர்க தமிழர் Jai Hind --------------------------------------------------------------------------------------- Our Criss Cross Tamizh(CCT) social platform Share your thoughts with us :  Twitter : https://twitter.com/CrissTamizh?s=09 Instagram : https://instagram.com/crisscrosstamizh?igshid=1ogeqeggzu05j Let' s have a conversation : Telegram : https://t.me/crisscrosstamizh

Criss Cross Tamizh
We are a You Tube channel and if you fell that the videos are too long out there you can now hear only the audio out here.. Sinthipom Seiyal Paduvom Jai Hind..